Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential
Andrea Chiricozzi,1,2 Clara De Simone,1,2 Barbara Fossati,2 Ketty Peris1,21Institute of Dermatology, Catholic University, Rome, Italy; 2Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, ItalyAbstract: Plaque psoriasis (PsO) is a chronic inflammatory skin disorder that may be associated wi...
Saved in:
Main Authors: | Chiricozzi A (Author), De Simone C (Author), Fossati B (Author), Peris K (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential [Corrigendum]
by: Chiricozzi A, et al.
Published: (2019) -
Bimekizumab for the treatment of moderate-to-severe plaque psoriasis: a meta-analysis of randomized clinical trials
by: Yuqian Wang, et al.
Published: (2023) -
An Overview of Bimekizumab for the Treatment of Psoriatic Arthritis: The Evidence so Far
by: G Oliveira D, et al.
Published: (2021) -
Bimekizumab as treatment for moderate to severe chronic plaque psoriasis: Real world clinical experience from a district general hospital setting
by: Omowunmi Ashaolu, et al.
Published: (2024) -
Eczematous eruption during bimekizumab treatment in a psoriatic patient previously treated with secukinumab
by: Gennaro Marco Falco, et al.
Published: (2024)